EN | KO
Organoid Culture Platform · NoStir Technology

Is your current organoid culture
approach truly sufficient?

PAIN 01 · PRODUCTIVITY

Batch-to-Batch Organoid Quality Variation

Physical stress from stirrer-based culture damages organoids, causing variable viability and yield across batches.

PAIN 02 · WORK EFFICIENCY

Frequent Weekend Work Just to Monitor Cultures

In conventional impeller/shaking-based culture, real-time morphological observation is not possible and media exchange automation is difficult.

Fluid-Controlled Static Suspension Culture

Conventional Method

Dynamic Suspension
Stirrer-based

  • Continuous physical stress from stirring
  • Batch-to-batch quality variation
  • No real-time organoid morphology observation
VS
NoStir Platform

Static Suspension
Fluid-controlled

  • High viability without physical stress
  • Stable, predictable culture quality
  • Real-time organoid morphology observation
  • Improved efficiency via remote monitoring
Conventional

Dynamic Suspension

Impeller / Wheel / Orbital Stirring

⚠ High physical stress → cell damage
⚠ No real-time morphology observation
✓ High uniformity · scalable to large volume
NoStir Platform

Static Suspension (Fluid-controlled)

Pump-based fluid control · TEB technology

✓ No physical stress → high viability
✓ Real-time organoid morphology observation
✓ Cell-friendly environment · high automation efficiency
Animation Speed 3

3 Core Values for Researchers

High Viability Maintenance

Organoids cultured in a static suspension environment maintain high viability and functionality without physical stress.

Real-time Morphology Observation

Organoids can be observed in real-time inside the chamber, reducing monitoring burden and the need for weekend check-ins.

Predictable Culture Quality

Disposable culture chambers and standardized fluid control minimize batch variation and ensure consistent organoid quality.

Tell us about your field experience

Please share your experience with the questions below. Your insights from the field help us understand real challenges and develop better solutions for the organoid culture community.

QUESTION 01 · Pain Point

Is it difficult to observe organoid morphology in real-time or automate media exchange in your current culture workflow?

This question concerns the lack of real-time observation and automation challenges in conventional stirrer-based 3D culture systems.

QUESTION 02 · Quality Issue

Have you experienced batch-to-batch quality variation in your organoid cultures that affected your research or production?

This question is about yield inconsistency, low viability, or reduced functionality causing delays in experiments or production.

Interested in participating in user testing or requesting a sample of the NoStir Platform?
Join us as an early research partner — your field experience will directly shape our technology development.

Learn More / Contact Us
Government Selection · 2026 Public Technology Commercialization Program
Selected for Market-Linked Startup Exploration Support Program
공공기술기반 시장연계 창업탐색 지원사업
2026
Company
Braxcell Systems Inc.
Stage
Pre-startup Team
Core Technology
TEB (Turbulent Eddy Breaker)
NoStir Platform
Target
Organoid Therapeutics
R&D / Manufacturers (B2B)